John Wylder Dubose, MD Psychiatry & Neurology - Addiction Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 S Main St, Ste 100, Mount Holly, NC 28120 Phone: 704-302-8555 |
News Archive
Premera Blue Cross today announced an important collaboration with Microsoft aimed at providing Microsoft employees with integrated, personal health records. Premera is combining its data and expertise with Microsoft's technology to provide the company's employees with greater visibility to their spending and healthcare claims through a connection to Microsoft HealthVault – a personal health application platform available to consumers.
The battle concerns state notification laws that would require pharmacists to notify doctors and patients when they substitute generic versions of drugs derived from living organisms known as biologics.
The Boston Globe: "Massachusetts health officials published online yesterday the most comprehensive state database in the country listing payments drug companies and medical device makers have made to doctors, nurses, pharmacists, hospitals, and other health care providers. The report lists $35.7 million in payments from hundreds of companies for the six months between July 1 and Dec. 31, 2009 … About half of that money, or $16.4 million, went to physicians. This is the first time Massachusetts has made such information public.
Which antiplatelet medication is best after a coronary stent? The Tailored Antiplatelet Therapy to Lessen Outcomes After Percutaneous Coronary Intervention (TAILOR-PCI) Study examines whether prescribing heart medication based on a patient's CYP2C19 genotype will help prevent heart attack, stroke, unstable angina, and cardiovascular death in patients who undergo percutaneous coronary intervention (PCI), commonly called angioplasty.
In a session at the 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference in Nairobi, Kenya, experts discussed the tools required to eradicate the disease and highlighted insecticide and drug resistance in some parts of the world, Xinhua reports. Researchers noted that resistance to artemisinin-based combination therapies (ACTs) has been documented in western Cambodia and "has now also been reported in the west of Thailand and in eastern Myanmar," the news service writes (Ooko/Zhuoyun, 11/5).
› Verified 1 days ago